2022
DOI: 10.3233/jad-215567
|View full text |Cite
|
Sign up to set email alerts
|

Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease

Abstract: Background: Neurofibrillary tangle (NFT) accumulation in the entorhinal cortex (EC) precedes the transformation from cognitive controls to mild cognitive impairment and Alzheimer’s disease (AD). While tauopathy has been described in the EC before, the order and degree to which the individual subfields within the EC are engulfed by NFTs in aging and the preclinical AD stage is unknown. Objective: We aimed to investigate substructures within the EC to map the populations of cortical neurons most vulnerable and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
58
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 20 publications
(63 citation statements)
references
References 85 publications
3
58
2
Order By: Relevance
“…Within the EC, posterior‐lateral subfields ECL, ELc, and ECs Lat , respectively, showed the highest semi‐quantitative pTDP‐43 density scores, while EO had the lowest (Figure 3A). Our finding of a posterior‐lateral EC vulnerability to pTDP‐43 complements molecular characterizations of vulnerable caudal EC neurons [42], PET imaging observations [43], the p‐tau gradient in subfields [32], and the use of lateral EC atrophy as a potential biomarker of preclinical AD [44, 45]. Two reports support a prion‐like seeding mechanism involved in TDP‐43 spread [46, 47], and recent hippocampal data from FTD patients suggest that TDP‐43 pathology spreads along trans‐synaptic connections [48].…”
Section: Discussionsupporting
confidence: 72%
“…Within the EC, posterior‐lateral subfields ECL, ELc, and ECs Lat , respectively, showed the highest semi‐quantitative pTDP‐43 density scores, while EO had the lowest (Figure 3A). Our finding of a posterior‐lateral EC vulnerability to pTDP‐43 complements molecular characterizations of vulnerable caudal EC neurons [42], PET imaging observations [43], the p‐tau gradient in subfields [32], and the use of lateral EC atrophy as a potential biomarker of preclinical AD [44, 45]. Two reports support a prion‐like seeding mechanism involved in TDP‐43 spread [46, 47], and recent hippocampal data from FTD patients suggest that TDP‐43 pathology spreads along trans‐synaptic connections [48].…”
Section: Discussionsupporting
confidence: 72%
“…Second, these results demonstrate concordance between patterns of microscopic NFT pathology, specific to pathologically confirmed AD, and macroscopic ex vivo measures of atrophy through reconstruction of microscopic measures in the dense, submillimeter metric of high field MRI. Previous studies have shown correlation between single time point ex vivo measures of thickness and levels of NFT and TDP-43 pathology, particularly in the areas of ERC and hippocampus ( Ravikumar et al, 2021 , Llamas-Rodríguez et al, 2022 ). Here, we show significant atrophy rates measured longitudinally in vivo in both the ERC and amygdala, which are correspondingly supported by our observation of highest densities of NFTs in our postmortem specimens not only in the ERC, but also in the amygdala.…”
Section: Discussionmentioning
confidence: 96%
“…Regarding ex vivo analysis, other efforts to reconstruct distributions of tau pathology in 3D include efforts to analyze concordance of distributions between subjects in early AD ( Ravikumar et al, 2021 , Yushkevich et al, 2021 , Llamas-Rodríguez et al, 2022 ) and to develop validation measures for in vivo molecular imaging ( Ushizima et al, 2022 ). These studies harbor advantages in terms of number of samples ( Ravikumar et al, 2021 , Yushkevich et al, 2021 , Llamas-Rodríguez et al, 2022 ) and scope of brain region (e.g. whole brain) ( Ushizima et al, 2022 ) analyzed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…All cases were assessed with gross tissue inspection and Luxol fast blue as well as Hematoxylin & Eosin staining were applied to rule out vascular disease and stroke. Immunohistochemistry for phosphorylated tau was used and all cases were staged for Braak & Braak (MPF, JCA) [41][42][43] . Subsequently, one case was diagnosed as normal control, three as Braak and Braak I, and three as Braak and Braak II.…”
Section: Methodsmentioning
confidence: 99%